Jalali Shahrzad, Ansell Stephen M
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Division of Hematology and Internal Medicine, Mayo Clinic, Rochester, MN, USA.
Best Pract Res Clin Haematol. 2016 Jun;29(2):148-155. doi: 10.1016/j.beha.2016.08.016. Epub 2016 Sep 4.
Waldenstrom Macroglobulinemia (WM) is a low-grade B-cell lymphoma defined firstly by infiltration of lymphoplasmacytic cells into the bone marrow (BM), the milieu where the cells acquire signals that promote malignant growth and proliferation. A second characteristic associated with WM is the increased synthesis of monoclonal immunoglobulin M (IgM) by lymphoplasmacytic cells, which is secreted in the serum and often results in hyperviscosity. Advanced genomic tools have improved our understanding of the genetic events that contribute to malignant transformation in WM, but the role of BM microenvironment is also emerging as having an essential role in WM disease progression. Therefore, delineation of malignant WM cell growth in the context of its microenvironment would benefit the design of more efficient therapeutic strategies. Here, we highlight available data regarding the interaction of the WM cells with the cellular and non-cellular compartments of the BM and discuss how BM provides a permissive environment for WM cell growth and proliferation.
华氏巨球蛋白血症(WM)是一种低度B细胞淋巴瘤,首先表现为淋巴浆细胞浸润骨髓(BM),骨髓是细胞获取促进恶性生长和增殖信号的环境。与WM相关的另一个特征是淋巴浆细胞合成单克隆免疫球蛋白M(IgM)增加,IgM分泌到血清中,常导致血液黏稠度增加。先进的基因组工具增进了我们对导致WM恶性转化的遗传事件理解,但骨髓微环境的作用也逐渐显现出在WM疾病进展中起着至关重要的作用。因此,在其微环境背景下描绘恶性WM细胞生长情况将有助于设计更有效的治疗策略。在此,我们重点介绍有关WM细胞与骨髓细胞及非细胞成分相互作用的现有数据,并讨论骨髓如何为WM细胞生长和增殖提供适宜环境。